Which pharmaceutical companies spent the most in R&D?

Published: 2017-12-01 13:06:18

Updated: 2017-12-01 13:06:18

KOSPI pharmaceutical companies increased collective R&D expenses by this 3^rd quarter year-on-year, but KOSDAQ pharmaceutical companies had a decrease. When it comes to the collective 3^rd quarter’s R&D expense/sales rate, the KOSDAQ market had a higher rate than the KOSPI.

Yakup Shinmoon(www.yakup.com) analyzed collective R&D expenses 34 KOSPI(Jeil Pharmaceutical excluded) and 31 KOSDAQ pharmac...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.